Adamas Pharmaceuticals, Inc. announced that on September 13, 2018, Richard A. King, Chief Operating Officer of the company, that effective September 15, 2018, he will depart from his position as Chief Operating Officer for personal reasons. Dean Hart, Senior Vice President of Sales, and Melissa Masterson, Senior Vice President of Commercial Operations and Market Access, will continue to lead the commercial efforts, reporting directly to Gregory Went, Chief Executive Officer.